Doxazosin in the treatment of patients with mild or moderate hypertension and mild or moderate renal insufficiency

American Heart Journal

Volumn 116, Issue 6 PART 2, 1988, Pages 1772-1777

  Bartels, Alien C C ^a,b,c,d   de Vries, Peter M J M ^a,b,c,d   Oe, Liem P ^a,b,c,d   van Bronswÿk, Hans ^a,b,c,d   Donker, Ab J M ^a,b,c,d   Réveillaud, René Jean ^a,b,c,d   Fillastre, Jean Paul ^a,b,c,d   Zech, Paul ^a,b,c,d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Service de Dermatologie   (France)

^c Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DOXAZOSIN; HIGH DENSITY LIPOPROTEIN;

ADULT; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SIDE EFFECT; WEIGHT GAIN;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CORONARY DISEASE; DOXAZOSIN; FEMALE; HEART RATE; HUMAN; HYPERTENSION; KIDNEY DISEASES; LIPIDS; MALE; MIDDLE AGE; PRAZOSIN;

EID: 0024263750     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/0002-8703(88)90228-1     Document Type: Article

References (17)

1. Postjunctional selectivity of alpha-blockade with prazosin, trimazosin and UK-33,274 in man
2. Clinical pharmacology of doxazosin in patients with essential hypertension
3. Doxazosin in patients with hypertension
4. Doxazosin, an alpha-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man
5. A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist doxazosin (UK-33274) in normotensive subjects
6. The metabolism and kinetics of doxazosin in man mouse rat and dog
7. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins
8. Multicentre 12-week double-blind comparison of doxazosin prazosin and placebo in patients with mild to moderate essential hypertension
9. Summary estimates of cholesterol use to predict coronary heart disease
10. Studies on the nature and causes of hyperlipidemia in uremia, maintenance dialysis and renal transplantation
11. Plasma high density lipoprotein concentrations in chronic hemodialysis and renal transplant patients
12. Coronary risk prediction in adults
13. A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension
14. Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise
15. Beta-blockers and plasma triglycerides [Letter]
16. Effect of propranolol and prazosin on blood lipids. The Oslo Study
17. Effects of diuretics on plasma lipoproteins in healthy men